Company / R&D per Share
Caris Life Sciences, Inc. R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.78
FY2025
5-year range
$2.78 / $3.34
FY2023-FY2025
Trend
-13.3%
vs FY2024
Sector context
#26 of 109
Health Care
What the data says
Caris Life Sciences, Inc.'s r&d per share of $2.78 is higher than 76% of companies in the Health Care sector (FY2025). Declined from $3.34 to $2.78 over the past 2 years.
Based on SEC 10-K filings.
2.78 in FY2025. Top quartile in the Health Care sector.
Declined from $3.34 to $2.78 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 109This company $2.78 Sector average $2.08
▼
+34.0% above sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 13.3% year-over-year.
- Ranks #26 out of 109 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.78 | -13.3% |
| FY2024 | $3.21 | -4.1% |
| FY2023 | $3.34 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026